Skip to main content
Caplight Logo









Ceruvia Lifesciences

Ceruvia Lifesciences

Private
Greenwich, ConnecticutHealthcare & Life Scienceshttps://ceruvialifesciences.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ceruvia Lifesciences is a clinical-stage biopharmaceutical company that researches, develops, and commercializes neurotransformational medicines to treat psychiatric and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalpsychedelic medicinepsychedelic therapydrug developmentclinical trialsneurotransformational medicinepsilocybinLSD analogmental healthpsychedelicsbiotechneurological disorderspsychiatric disordersdrug discoverypsychedelic biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ceruvia Lifesciences Comparables

Compare Ceruvia Lifesciences with similar companies based on industry and business-model similarity.

Ceruvia Lifesciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
B. More Inc.
88%
Lophora
86%
Delix Therapeutics
85%

Ceruvia Lifesciences Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Paul E. Bezodis

Fractional COO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 301% MoM.

  • Jun 18, 2026

    Monthly visitors grew 102% MoM.

Recent news

Latest coverage and updates

  • receives_financingAug 3, 2026

    Ceruvia Life Sciences was planning to receive financing of $8M on Aug 3rd '26.

  • receives_financingAug 3, 2026

    Ceruvia Life Sciences received financing of $8M in investment on Aug 1st '26.

Ceruvia Lifesciences Filings

Explore SEC and related filing metadata, where available.

Ceruvia Lifesciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ceruvia Lifesciences's valuation, stock price, and market status.

Is Ceruvia Lifesciences a public or private company?

Ceruvia Lifesciences is a private company.

What is the current stock price of Ceruvia Lifesciences?

Ceruvia Lifesciences is a private company with no public stock price. No recent secondary market data is available.

How much is Ceruvia Lifesciences worth (valuation)?

Valuation information for Ceruvia Lifesciences is not publicly available.

Can I buy Ceruvia Lifesciences stock?

Ceruvia Lifesciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ceruvia Lifesciences's last funding round?

Funding round information for Ceruvia Lifesciences is not publicly available.

Who are the main investors in Ceruvia Lifesciences?

Investor information for Ceruvia Lifesciences is not publicly disclosed.

Will Ceruvia Lifesciences IPO soon?

No public IPO plans have been announced for Ceruvia Lifesciences.

How can I track Ceruvia Lifesciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ceruvia Lifesciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGreenwich, Connecticut
Employee Range3
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?